# ACZ885 in Type 1 Diabetes Mellitus

> **NCT01322321** · PHASE2 · WITHDRAWN · sponsor: **Novartis Pharmaceuticals**

## Conditions studied

- Diabetes Mellitus
- Diabetes Type 1

## Interventions

- **DRUG:** ACZ885
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01322321
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2011-03
- **Primary completion:** 2011-06
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2012-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01322321

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01322321, "ACZ885 in Type 1 Diabetes Mellitus". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT01322321. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*